--- Chain 1 for Question 102 ---
Status: USED_FOR_VOTING
Finish Reason (Model): stop
Extracted Answer: D
Prompt Tokens (Usage): 439
Completion Tokens (Usage): 3660
Reasoning Tokens (Counted): 3099
Non-Reasoning Tokens (Counted): 559
Total Tokens (Usage): N/A

--- Reasoning Content ---
Okay, so I have this question about a scientific experiment involving a ligand-receptor pair. I'm a bit new to this, but I'll try to think it through step by step.

The question describes a bicistronic lox-Cre vector. Bicistronic means it has two coding regions, right? So the vector has two ORFs: the ligand and the receptor. The ligand is at the 5' end, fused to mCherry, and the receptor is at the 3' end with eGFP at the C-terminus. 

The promoters are important here. The ligand is under the CBA promoter, which I think is a strong promoter, maybe constitutive. Upstream of the receptor is the IRES element. IRES allows for internal ribosome entry, meaning it can drive the expression of the receptor without needing a separate promoter. So both ligand and receptor are being expressed, but perhaps the receptor's expression is dependent on the IRES.

Now, the vector has these stop cassettes. Between the ligand and mCherry is a loxP-stop-loxP cassette. Similarly, the receptor has a lox2272-stop-lox2272 cassette before eGFP. Oh, wait, I remember that loxP and lox2272 are different lox sites. Cre recombinase recognizes loxP sites. So when Cre is present, it will excise the stop cassette, allowing the downstream gene to be expressed.

In the experiment, they transfected the plasmid into primary astrocyte culture and used antibodies against the overexpressed proteins on a Western blot. So initially, they should see expression of both ligand-mCherry and receptor-eGFP, unless something's wrong.

Then, they made a mouse model that's homozygous for the construct. They crossed it with SOX10-Cre hemizygous mice. SOX10 is a transcription factor important in neural crest development. Cre is used here to excise the stop cassettes, I suppose. So in the offspring, the Cre should remove the appropriate lox sites to allow expression.

But when they looked under the confocal, they didn't see a green signal. The eGFP should be in the receptor, so if the receptor is expressed, they should see green in the cells where the receptor is made.

Why didn't they see green? Let's look at the options.

Option A: Ligand and receptor are paracrine. Paracrine means they act on nearby cells, but I don't see how that would prevent the receptor from being expressed. They used antibodies, so Western blot should have shown expression regardless of function. Plus, the question is about the construct's expression, not the function.

Option B: Receptor-eGFP stuck in the Golgi. If it's stuck, then it wouldn't reach the cell surface, but the question is about expression. They should see the protein via Western blot. The Western blot uses total proteins, so if it's stuck in Golgi, it would still be present, just not on the membrane. Probably not the issue since the blot would detect it.

Option C: Enhancer missing. The ligand is under CBA, which is a strong promoter. The receptor uses IRES, which doesn't require a promoter. So maybe the enhancer is missing for one of them? But the vector design includes the necessary elements. Unless the IRES isn't functional without an enhancer. Wait, IRES elements typically don't require enhancers because they work via internal initiation. So if they're using an IRES, it shouldn't need an enhancer. But if the vector doesn't have the right sequences, maybe the receptor isn't expressed. But in this case, the vector has IRES upstream of the receptor, so that should allow expression when the stop is removed.

Option D: Receptor and eGFP not in frame. Oh, right, when you do a fusion protein, the reading frame must be correct. If the ORF of the receptor is not in frame with eGFP, the protein won't be expressed properly. So, for example, if the stop codon is before the eGFP, but the stop is part of the lox2272 cassette. Wait, the construct is ReceptorORF followed by a stop in a lox2272 cassette, then eGFP. So when Cre is present, it would excise the stop, and the receptor would be followed by eGFP in the same frame. If they're not in frame, the fusion wouldn't work, meaning eGFP wouldn't be made. So how would that affect expression?

Wait, the vector is ligand ORF (with loxP stop) fused to mCherry, and receptor ORF (with lox2272 stop) fused to eGFP. When Cre is present (like in the SOX10-Cre mice), the loxP sites would be recombined. SOX10 is expressed in neural crest cells, which is where the ligand and receptor are initially expressed.

So in the mouse, the Cre would excise the loxP stop in the ligand's cassette, so the ligand would be expressed along with mCherry. Similarly, the lox2272 stop in the receptor's cassette would be excised, allowing the receptor to be expressed along with eGFP.

Wait, but the problem is that after crossing, they don't see green. So the eGFP isn't expressed. Looking at the options again.

If the receptor and eGFP are not in frame, then the construct would produce a nonfunctional protein. But would that prevent eGFP from being expressed? Or would it still produce the eGFP as a separate part?

Wait, no. Let's think about the vector. The receptor ORF is in frame with eGFP. So the construct is Receptor-eGFP as a single protein. If the frames are not aligned, the entire construct may not be translated beyond the receptor or eGFP might not be correctly appended.

Alternatively, if the eGFP is after the receptor, and the stop is removed, but the frame is wrong, the eGFP might not be expressed. So in the mouse, the Cre would allow the receptor ORF to be expressed, but if the eGFP is not in frame, it would either produce a truncated protein (if the frame is wrong) or no eGFP at all. Wait, but if it's a fusion, the eGFP is part of the same reading frame as the receptor. So if the frames are not aligned, the entire construct might not be expressed.

Wait, let's think about the vector. The vector has the ligand ORF, followed by a stop cassette (loxP), then mCherry. The other side has the receptor ORF, followed by a stop cassette (lox2272), then eGFP. So when Cre is present, the stop cassettes are removed. So the ligand is expressed as ligand-mCherry, and the receptor as receptor-eGFP.

If the eGFP is not in frame, then the receptor would be expressed, but eGFP would not. So the Western blot would detect the receptor, but not eGFP. But in the mouse, they're using confocal to look for eGFP. So if eGFP isn't expressed, that's why they don't see the green signal.

But wait, why would the eGFP not be expressed? Maybe because the stop cassette wasn't properly removed, but SOX10-Cre is active in neural crest cells where the ligand and receptor are expressed. So Cre should have acted on the lox2272 sites.

Alternatively, perhaps the problem is that the lox sites are not compatible. LoxP is recognized by Cre, and lox2272 is recognized by another recombinase, but if the same Cre can't recognize lox2272, then the stop cassette wouldn't be removed.

Wait, I think lox2272 is a variant of loxP that is Cre-recognizable but can mediate recombination without the need for the same orientation. Or perhaps the vector has loxP and lox2272 in opposite orientations. Wait, I'm a bit shaky on this. LoxP is a 34 bp site, and lox2272 is a mutant version. The key is that Cre can mediate recombination between loxP and lox2272 sites, but whether it's efficient depends on the orientation and the presence of the right enzymes.

Wait, but in this case, the vector has loxP in the ligand stop cassette, and lox2272 in the receptor stop cassette. So when Cre is expressed, it should recognize both sites. Because Cre can recombine between loxP and lox2272. So the stop cassettes should be excised, allowing both ligand and receptor to be expressed.

So why isn't eGFP expressed? Let's think about the options again.

Option D says the receptor and eGFP are not in frame. That would result in eGFP not being expressed. So when they look for eGFP, there's nothing. But why would the frames not be correct?

If the vector was designed with a Kozak sequence or start codon in the wrong place, the receptor might be translated in a different frame than eGFP. So when the stop is removed, the eGFP isn't correctly appended. So when the mouse is made, the receptor is expressed, but eGFP isn't.

Wait, but the vector is designed so that the receptor ORF is followed by the stop, and then eGFP. So when the stop is removed, the receptor is expressed along with eGFP as a fusion. So the construct would be Receptor-eGFP.

If the ORFs are not in frame, that fusion wouldn't work. So perhaps the eGFP isn't being translated because its frame is incorrect, so the Western blot wouldn't pick up eGFP, and thus the mouse doesn't show green.

But why would the frames be wrong? Maybe during cloning, the insert wasn't in the correct frame. The question states that the ligand and receptor are initially expressed in neural crest cells, so presumably the cloning is correct. Unless there was a cloning error, but that's not part of the question.

Alternatively, perhaps the vector's design for the receptor and eGFP is such that the reading frame isn't maintained. Suppose the stop was in a way that when removed, the eGFP starts in the correct frame. If not, then it's a problem.

Another possibility is that the IRES element isn't working. The receptor is under IRES, which requires the ribosome to initiate internally. If the IRES isn't functional, the receptor won't be expressed, but then how about the ligand? The ligand is under the CBA promoter, which should be expressed regardless.

Wait, in the initial Western blot, they saw expression of both proteins if the construct is working. But in the mouse, the Cre is supposed to remove the stops. If the IRES isn't working, perhaps the receptor isn't being expressed, so eGFP isn't either.

But the question says that the vector has the IRES upstream of the receptor, so after the stop is removed, the receptor should be expressed. If the IRES isn't functional, then the receptor wouldn't be expressed, regardless of the stop.

So the possible issues are:

- The IRES is not working, so the receptor isn't expressed. So Western blot in the mouse wouldn't show the receptor, but in the initial transfection, it's expressed.

Wait, but the initial experiment was in primary astrocyte culture, which might not have Cre. So the stop cassettes are still in place in the transfected cells. So the ligand and receptor wouldn't be expressed unless Cre is present. Wait, no. Because in the initial plasmid, the ligand is under the CBA promoter, which is constitutive. So the ligand would be expressed, but the receptor would be under the IRES, which requires the stop to be removed. Wait, no. The receptor's ORF is after the IRES. So in the absence of Cre, the receptor's ORF is behind a stop cassette. So in the initial transfection, without Cre, the receptor wouldn't be expressed because the stop cassette is in place. Only the ligand would be expressed, as the CBA promoter drives it, with mCherry.

But the Western blot after transfection used antibodies against overexpressed proteins. So perhaps they saw mCherry and eGFP? Wait, no, because without Cre, the receptor is still blocked. So the Western blot wouldn't show the receptor or eGFP. But the question says that after transfection, they used the antibodies and saw a signal proportional to actin. So I'm a bit confused.

Wait, maybe when they transfected the plasmid into astrocytes, the plasmid doesn't have Cre, so the stop cassettes aren't removed. Thus, the ligand is expressed with mCherry, and the receptor isn't. So on Western blot, they would see the ligand-mCherry but not the receptor-eGFP. But the question says the signal is proportional to actin, which is just a loading control. It doesn't say whether the proteins were detected.

Hmm, maybe I'm getting off track. Let's go back to the main experiment. The mouse model is homozygous for the construct. They crossed with SOX10-Cre, which would express Cre in neural crest cells and their derivatives, including astrocytes. So in the offspring, the Cre should have removed the stop cassettes. So the ligand and receptor should be expressed.

But they don't see eGFP in the confocal. So the possible explanations are:

A) They're in paracrine, so you don't see it in the same cell. But the eGFP is a fusion with the receptor, so it should be expressed in the same cells as the receptor.

B) Receptor stuck in Golgi. But Western blot would detect it.

C) Enhancer missing. But the receptor uses IRES, which doesn't need enhancers.

D) Receptor and eGFP not in frame. So the eGFP isn't expressed.

So the most likely answer is D. Because if the receptor and eGFP are not in frame, the fusion protein isn't made, so eGFP isn't expressed. Hence, no green signal.


--- Final Answer Content ---


The question involves a bicistronic lox-Cre vector expressing a ligand and receptor, with the ligand under the CBA promoter and the receptor under an IRES element. The ligand ORF is fused to mCherry, and the receptor ORF is fused to eGFP. Stop cassettes (loxP-stop-loxP for the ligand and lox2272-stop-lox2272 for the receptor) are present, which can be excised by Cre recombinase to allow expression of the downstream genes. After crossing mice homozygous for the construct with SOX10-Cre hemizygous mice, no green signal (eGFP) was observed under confocal microscopy.

### Key Analysis of the Options:

1. **Option A: Ligand and receptor are in a paracrine relationship**  
   A paracrine relationship describes signaling between nearby cells, but this does not explain the lack of eGFP expression. The question focuses on the construct's expression, not the functional interaction between ligand and receptor. Additionally, eGFP is a fusion with the receptor, so it should be expressed in the same cells as the receptor. This option does not address the issue.

2. **Option B: The receptor-eGFP construct is stuck in the Golgi**  
   If the receptor-eGFP were stuck in the Golgi, it would still be detectable in total protein extracts via Western blot. Since the question does not mention Western blot results supporting this, and the focus is on the absence of eGFP in the confocal microscopy, this is unlikely to be the cause.

3. **Option C: The enhancer for the ligand and receptor expression is missing**  
   The ligand is under the CBA promoter, which is constitutive and does not require an enhancer. The receptor is under an IRES element, which also does not require an enhancer for its internal ribosome entry mechanism. Therefore, the absence of an enhancer is not a plausible explanation for the lack of eGFP expression.

4. **Option D: The receptor and eGFP are not in frame**  
   If the receptor and eGFP are not in the same reading frame, the fusion protein would not be expressed correctly. This would result in the absence of eGFP expression, even if the stop cassette is excised by Cre. Since the confocal microscopy did not show a green signal, this is the most likely explanation.

### Conclusion:
The absence of the green signal in the confocal microscopy is most likely due to the receptor and eGFP not being in frame, preventing proper expression of the fusion protein. 

Answer: D

--- Full Content ---
Okay, so I have this question about a scientific experiment involving a ligand-receptor pair. I'm a bit new to this, but I'll try to think it through step by step.

The question describes a bicistronic lox-Cre vector. Bicistronic means it has two coding regions, right? So the vector has two ORFs: the ligand and the receptor. The ligand is at the 5' end, fused to mCherry, and the receptor is at the 3' end with eGFP at the C-terminus. 

The promoters are important here. The ligand is under the CBA promoter, which I think is a strong promoter, maybe constitutive. Upstream of the receptor is the IRES element. IRES allows for internal ribosome entry, meaning it can drive the expression of the receptor without needing a separate promoter. So both ligand and receptor are being expressed, but perhaps the receptor's expression is dependent on the IRES.

Now, the vector has these stop cassettes. Between the ligand and mCherry is a loxP-stop-loxP cassette. Similarly, the receptor has a lox2272-stop-lox2272 cassette before eGFP. Oh, wait, I remember that loxP and lox2272 are different lox sites. Cre recombinase recognizes loxP sites. So when Cre is present, it will excise the stop cassette, allowing the downstream gene to be expressed.

In the experiment, they transfected the plasmid into primary astrocyte culture and used antibodies against the overexpressed proteins on a Western blot. So initially, they should see expression of both ligand-mCherry and receptor-eGFP, unless something's wrong.

Then, they made a mouse model that's homozygous for the construct. They crossed it with SOX10-Cre hemizygous mice. SOX10 is a transcription factor important in neural crest development. Cre is used here to excise the stop cassettes, I suppose. So in the offspring, the Cre should remove the appropriate lox sites to allow expression.

But when they looked under the confocal, they didn't see a green signal. The eGFP should be in the receptor, so if the receptor is expressed, they should see green in the cells where the receptor is made.

Why didn't they see green? Let's look at the options.

Option A: Ligand and receptor are paracrine. Paracrine means they act on nearby cells, but I don't see how that would prevent the receptor from being expressed. They used antibodies, so Western blot should have shown expression regardless of function. Plus, the question is about the construct's expression, not the function.

Option B: Receptor-eGFP stuck in the Golgi. If it's stuck, then it wouldn't reach the cell surface, but the question is about expression. They should see the protein via Western blot. The Western blot uses total proteins, so if it's stuck in Golgi, it would still be present, just not on the membrane. Probably not the issue since the blot would detect it.

Option C: Enhancer missing. The ligand is under CBA, which is a strong promoter. The receptor uses IRES, which doesn't require a promoter. So maybe the enhancer is missing for one of them? But the vector design includes the necessary elements. Unless the IRES isn't functional without an enhancer. Wait, IRES elements typically don't require enhancers because they work via internal initiation. So if they're using an IRES, it shouldn't need an enhancer. But if the vector doesn't have the right sequences, maybe the receptor isn't expressed. But in this case, the vector has IRES upstream of the receptor, so that should allow expression when the stop is removed.

Option D: Receptor and eGFP not in frame. Oh, right, when you do a fusion protein, the reading frame must be correct. If the ORF of the receptor is not in frame with eGFP, the protein won't be expressed properly. So, for example, if the stop codon is before the eGFP, but the stop is part of the lox2272 cassette. Wait, the construct is ReceptorORF followed by a stop in a lox2272 cassette, then eGFP. So when Cre is present, it would excise the stop, and the receptor would be followed by eGFP in the same frame. If they're not in frame, the fusion wouldn't work, meaning eGFP wouldn't be made. So how would that affect expression?

Wait, the vector is ligand ORF (with loxP stop) fused to mCherry, and receptor ORF (with lox2272 stop) fused to eGFP. When Cre is present (like in the SOX10-Cre mice), the loxP sites would be recombined. SOX10 is expressed in neural crest cells, which is where the ligand and receptor are initially expressed.

So in the mouse, the Cre would excise the loxP stop in the ligand's cassette, so the ligand would be expressed along with mCherry. Similarly, the lox2272 stop in the receptor's cassette would be excised, allowing the receptor to be expressed along with eGFP.

Wait, but the problem is that after crossing, they don't see green. So the eGFP isn't expressed. Looking at the options again.

If the receptor and eGFP are not in frame, then the construct would produce a nonfunctional protein. But would that prevent eGFP from being expressed? Or would it still produce the eGFP as a separate part?

Wait, no. Let's think about the vector. The receptor ORF is in frame with eGFP. So the construct is Receptor-eGFP as a single protein. If the frames are not aligned, the entire construct may not be translated beyond the receptor or eGFP might not be correctly appended.

Alternatively, if the eGFP is after the receptor, and the stop is removed, but the frame is wrong, the eGFP might not be expressed. So in the mouse, the Cre would allow the receptor ORF to be expressed, but if the eGFP is not in frame, it would either produce a truncated protein (if the frame is wrong) or no eGFP at all. Wait, but if it's a fusion, the eGFP is part of the same reading frame as the receptor. So if the frames are not aligned, the entire construct might not be expressed.

Wait, let's think about the vector. The vector has the ligand ORF, followed by a stop cassette (loxP), then mCherry. The other side has the receptor ORF, followed by a stop cassette (lox2272), then eGFP. So when Cre is present, the stop cassettes are removed. So the ligand is expressed as ligand-mCherry, and the receptor as receptor-eGFP.

If the eGFP is not in frame, then the receptor would be expressed, but eGFP would not. So the Western blot would detect the receptor, but not eGFP. But in the mouse, they're using confocal to look for eGFP. So if eGFP isn't expressed, that's why they don't see the green signal.

But wait, why would the eGFP not be expressed? Maybe because the stop cassette wasn't properly removed, but SOX10-Cre is active in neural crest cells where the ligand and receptor are expressed. So Cre should have acted on the lox2272 sites.

Alternatively, perhaps the problem is that the lox sites are not compatible. LoxP is recognized by Cre, and lox2272 is recognized by another recombinase, but if the same Cre can't recognize lox2272, then the stop cassette wouldn't be removed.

Wait, I think lox2272 is a variant of loxP that is Cre-recognizable but can mediate recombination without the need for the same orientation. Or perhaps the vector has loxP and lox2272 in opposite orientations. Wait, I'm a bit shaky on this. LoxP is a 34 bp site, and lox2272 is a mutant version. The key is that Cre can mediate recombination between loxP and lox2272 sites, but whether it's efficient depends on the orientation and the presence of the right enzymes.

Wait, but in this case, the vector has loxP in the ligand stop cassette, and lox2272 in the receptor stop cassette. So when Cre is expressed, it should recognize both sites. Because Cre can recombine between loxP and lox2272. So the stop cassettes should be excised, allowing both ligand and receptor to be expressed.

So why isn't eGFP expressed? Let's think about the options again.

Option D says the receptor and eGFP are not in frame. That would result in eGFP not being expressed. So when they look for eGFP, there's nothing. But why would the frames not be correct?

If the vector was designed with a Kozak sequence or start codon in the wrong place, the receptor might be translated in a different frame than eGFP. So when the stop is removed, the eGFP isn't correctly appended. So when the mouse is made, the receptor is expressed, but eGFP isn't.

Wait, but the vector is designed so that the receptor ORF is followed by the stop, and then eGFP. So when the stop is removed, the receptor is expressed along with eGFP as a fusion. So the construct would be Receptor-eGFP.

If the ORFs are not in frame, that fusion wouldn't work. So perhaps the eGFP isn't being translated because its frame is incorrect, so the Western blot wouldn't pick up eGFP, and thus the mouse doesn't show green.

But why would the frames be wrong? Maybe during cloning, the insert wasn't in the correct frame. The question states that the ligand and receptor are initially expressed in neural crest cells, so presumably the cloning is correct. Unless there was a cloning error, but that's not part of the question.

Alternatively, perhaps the vector's design for the receptor and eGFP is such that the reading frame isn't maintained. Suppose the stop was in a way that when removed, the eGFP starts in the correct frame. If not, then it's a problem.

Another possibility is that the IRES element isn't working. The receptor is under IRES, which requires the ribosome to initiate internally. If the IRES isn't functional, the receptor won't be expressed, but then how about the ligand? The ligand is under the CBA promoter, which should be expressed regardless.

Wait, in the initial Western blot, they saw expression of both proteins if the construct is working. But in the mouse, the Cre is supposed to remove the stops. If the IRES isn't working, perhaps the receptor isn't being expressed, so eGFP isn't either.

But the question says that the vector has the IRES upstream of the receptor, so after the stop is removed, the receptor should be expressed. If the IRES isn't functional, then the receptor wouldn't be expressed, regardless of the stop.

So the possible issues are:

- The IRES is not working, so the receptor isn't expressed. So Western blot in the mouse wouldn't show the receptor, but in the initial transfection, it's expressed.

Wait, but the initial experiment was in primary astrocyte culture, which might not have Cre. So the stop cassettes are still in place in the transfected cells. So the ligand and receptor wouldn't be expressed unless Cre is present. Wait, no. Because in the initial plasmid, the ligand is under the CBA promoter, which is constitutive. So the ligand would be expressed, but the receptor would be under the IRES, which requires the stop to be removed. Wait, no. The receptor's ORF is after the IRES. So in the absence of Cre, the receptor's ORF is behind a stop cassette. So in the initial transfection, without Cre, the receptor wouldn't be expressed because the stop cassette is in place. Only the ligand would be expressed, as the CBA promoter drives it, with mCherry.

But the Western blot after transfection used antibodies against overexpressed proteins. So perhaps they saw mCherry and eGFP? Wait, no, because without Cre, the receptor is still blocked. So the Western blot wouldn't show the receptor or eGFP. But the question says that after transfection, they used the antibodies and saw a signal proportional to actin. So I'm a bit confused.

Wait, maybe when they transfected the plasmid into astrocytes, the plasmid doesn't have Cre, so the stop cassettes aren't removed. Thus, the ligand is expressed with mCherry, and the receptor isn't. So on Western blot, they would see the ligand-mCherry but not the receptor-eGFP. But the question says the signal is proportional to actin, which is just a loading control. It doesn't say whether the proteins were detected.

Hmm, maybe I'm getting off track. Let's go back to the main experiment. The mouse model is homozygous for the construct. They crossed with SOX10-Cre, which would express Cre in neural crest cells and their derivatives, including astrocytes. So in the offspring, the Cre should have removed the stop cassettes. So the ligand and receptor should be expressed.

But they don't see eGFP in the confocal. So the possible explanations are:

A) They're in paracrine, so you don't see it in the same cell. But the eGFP is a fusion with the receptor, so it should be expressed in the same cells as the receptor.

B) Receptor stuck in Golgi. But Western blot would detect it.

C) Enhancer missing. But the receptor uses IRES, which doesn't need enhancers.

D) Receptor and eGFP not in frame. So the eGFP isn't expressed.

So the most likely answer is D. Because if the receptor and eGFP are not in frame, the fusion protein isn't made, so eGFP isn't expressed. Hence, no green signal.


The question involves a bicistronic lox-Cre vector expressing a ligand and receptor, with the ligand under the CBA promoter and the receptor under an IRES element. The ligand ORF is fused to mCherry, and the receptor ORF is fused to eGFP. Stop cassettes (loxP-stop-loxP for the ligand and lox2272-stop-lox2272 for the receptor) are present, which can be excised by Cre recombinase to allow expression of the downstream genes. After crossing mice homozygous for the construct with SOX10-Cre hemizygous mice, no green signal (eGFP) was observed under confocal microscopy.

### Key Analysis of the Options:

1. **Option A: Ligand and receptor are in a paracrine relationship**  
   A paracrine relationship describes signaling between nearby cells, but this does not explain the lack of eGFP expression. The question focuses on the construct's expression, not the functional interaction between ligand and receptor. Additionally, eGFP is a fusion with the receptor, so it should be expressed in the same cells as the receptor. This option does not address the issue.

2. **Option B: The receptor-eGFP construct is stuck in the Golgi**  
   If the receptor-eGFP were stuck in the Golgi, it would still be detectable in total protein extracts via Western blot. Since the question does not mention Western blot results supporting this, and the focus is on the absence of eGFP in the confocal microscopy, this is unlikely to be the cause.

3. **Option C: The enhancer for the ligand and receptor expression is missing**  
   The ligand is under the CBA promoter, which is constitutive and does not require an enhancer. The receptor is under an IRES element, which also does not require an enhancer for its internal ribosome entry mechanism. Therefore, the absence of an enhancer is not a plausible explanation for the lack of eGFP expression.

4. **Option D: The receptor and eGFP are not in frame**  
   If the receptor and eGFP are not in the same reading frame, the fusion protein would not be expressed correctly. This would result in the absence of eGFP expression, even if the stop cassette is excised by Cre. Since the confocal microscopy did not show a green signal, this is the most likely explanation.

### Conclusion:
The absence of the green signal in the confocal microscopy is most likely due to the receptor and eGFP not being in frame, preventing proper expression of the fusion protein. 

Answer: D